BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21542925)

  • 21. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
    Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
    Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The heterogeneous nature of germline mutations in NF1 patients with malignant peripheral serve sheath tumours (MPNSTs).
    Upadhyaya M; Spurlock G; Majounie E; Griffiths S; Forrester N; Baser M; Huson SM; Gareth Evans D; Ferner R
    Hum Mutat; 2006 Jul; 27(7):716. PubMed ID: 16786508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.
    Lamm W; Schur S; Köstler WJ; Funovics P; Windhager R; Amann G; Panotopoulos J; Pokrajac B; Brodowicz T
    Oncology; 2014; 86(2):122-6. PubMed ID: 24480823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer in neurofibromatosis 1: survival and risk of contralateral breast cancer in a five country cohort study.
    Evans DGR; Kallionpää RA; Clementi M; Trevisson E; Mautner VF; Howell SJ; Lewis L; Zehou O; Peltonen S; Brunello A; Harkness EF; Wolkenstein P; Peltonen J
    Genet Med; 2020 Feb; 22(2):398-406. PubMed ID: 31495828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of 703 patients.
    Khosrotehrani K; Bastuji-Garin S; Riccardi VM; Birch P; Friedman JM; Wolkenstein P
    Am J Med Genet A; 2005 Jan; 132A(1):49-53. PubMed ID: 15523617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
    Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
    JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 26-year cohort mortality study of French construction workers aged 20 to 64 years.
    Thuret A; Geoffroy-Perez B; Luce D; Goldberg M; Imbernon E
    J Occup Environ Med; 2007 May; 49(5):546-56. PubMed ID: 17495697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.
    Friedrich RE; Beer C; Glatzel M; Hagel C
    Anticancer Res; 2015 Jan; 35(1):137-44. PubMed ID: 25550544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.
    LaFemina J; Qin LX; Moraco NH; Antonescu CR; Fields RC; Crago AM; Brennan MF; Singer S
    Ann Surg Oncol; 2013 Jan; 20(1):66-72. PubMed ID: 22878618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1.
    McCaughan JA; Holloway SM; Davidson R; Lam WW
    J Med Genet; 2007 Jul; 44(7):463-6. PubMed ID: 17327286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
    Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
    Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causes of death in people with celiac disease spanning the pre- and post-serology era: a population-based cohort study from Derby, UK.
    Grainge MJ; West J; Card TR; Holmes GK
    Am J Gastroenterol; 2011 May; 106(5):933-9. PubMed ID: 21245833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis type 1 and malignancy in childhood.
    Varan A; Şen H; Aydın B; Yalçın B; Kutluk T; Akyüz C
    Clin Genet; 2016 Mar; 89(3):341-5. PubMed ID: 26073032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Deaths in a Tunisian psychiatric hospital: an eleven-year retrospective study].
    Zgueb Y; Jomli R; Ouertani A; Hechmi S; Ouanes S; Nacef F; Banaser A
    Encephale; 2014 Oct; 40(5):416-22. PubMed ID: 25132014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant peripheral nerve sheath tumor of the vagus nerve in a teenager with the neurofibromatosis 1 gene mutation: a case report.
    Sesenna E; Magri AS; Corradi D; Ferri T; Ferri A
    J Pediatr Surg; 2011 Aug; 46(8):e9-12. PubMed ID: 21843710
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
    Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoproliferative malignancies in patients with neurofibromatosis 1.
    Bergqvist C; Hemery F; Jannic A; Ferkal S; Wolkenstein P
    Orphanet J Rare Dis; 2021 May; 16(1):230. PubMed ID: 34011343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.
    Thomas L; Mautner VF; Cooper DN; Upadhyaya M
    Hum Genomics; 2012 Sep; 6(1):18. PubMed ID: 23244685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study.
    Diaz E; Bergqvist C; Peiffer B; Fertitta L; Jannic A; Ferkal S; Zehou O; Hemery F; Sbidian E; Wolkenstein P
    J Invest Dermatol; 2023 Dec; 143(12):2408-2415.e7. PubMed ID: 37257636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality after discharge from acute care hospitalization with traumatic brain injury: a population-based study.
    Ventura T; Harrison-Felix C; Carlson N; Diguiseppi C; Gabella B; Brown A; Devivo M; Whiteneck G
    Arch Phys Med Rehabil; 2010 Jan; 91(1):20-9. PubMed ID: 20103393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.